skip to main content

GI Protection on DAPT — ESEGH MCQ

Instant feedback + full explanation. One question, done properly.

Hard"Gastroenterology"GI Protection on DAPTESEGH

A 58-year-old with compensated alcohol-related cirrhosis has no focal liver lesion and is suitable for hepatocellular-carcinoma treatment if a lesion develops. What surveillance programme is recommended?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Liver ultrasound every 6 months, with or without serum alpha-fetoprotein

Option B is correct: NICE recommends 6-monthly ultrasound surveillance, with or without AFP, for eligible adults with cirrhosis. Option A uses an annual CT-based programme. Option C is excessively intensive and uses a biliary marker. Option D adds PET-CT without a surveillance role, and option E relies on AFP as the primary trigger instead of scheduled imaging.

Reference: NICE NG50: cirrhosis in over 16s. https://www.nice.org.uk/guidance/ng50/chapter/recommendations